Clinical Trials Directory

Trials / Unknown

UnknownNCT03592446

Neural Alteration Response to Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Depressed Patients

Xidian University,China

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Xidian University · Academic / Other
Sex
All
Age
15 Years – 70 Years
Healthy volunteers
Accepted

Summary

Electrical vagus nerve stimulation (VNS) was approved by FDA for treatment of chronic recurrent depression in 2005. Recently, non-invasive, transcutaneous auricular vagus nerve stimulation (taVNS) has already been used for depression treatment. However, the neural mechanism remains unclear, and the relationship between stimulation parameters and neural response were also unknown. The present study aims to investigate the specific brain activation in depression patients after taVNS,compared with healthy controls.

Conditions

Interventions

TypeNameDescription
DEVICETranscutaneous electrical vagus nerve stimulationAll subjects receive electrical VNS stimulation at cymba conchae.
DEVICESham vagus nerve stimulationAll subjects receive electrical stimulation at earlobe.

Timeline

Start date
2018-09-01
Primary completion
2020-07-30
Completion
2020-07-30
First posted
2018-07-19
Last updated
2018-07-19

Source: ClinicalTrials.gov record NCT03592446. Inclusion in this directory is not an endorsement.